Article Text

PDF
Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus
  1. O Pech1,
  2. A Behrens1,
  3. A May1,
  4. L Nachbar1,
  5. L Gossner1,
  6. T Rabenstein1,
  7. H Manner1,
  8. E Guenter1,
  9. J Huijsmans1,
  10. M Vieth2,
  11. M Stolte2,
  12. C Ell1
  1. 1
    Department of Internal Medicine II, HSK Wiesbaden, Wiesbaden, Germany
  2. 2
    Institute of Pathology, Bayreuth Hospital, Bayreuth, Germany
  1. Professor C Ell, Department of Internal Medicine II, HSK Wiesbaden, Ludwig-Erhard-Strasse 100, 65199 Wiesbaden, Germany; ell.hsk-wiesbaden{at}arcor.de

Abstract

Objective: Endoscopic therapy is increasingly being used in the treatment of high-grade intraepithelial neoplasia (HGIN) and mucosal adenocarcinoma (BC) in patients with Barrett’s oesophagus. This report provides 5 year follow-up data from a large prospective study investigating the efficacy and safety of endoscopic treatment in these patients and analysing risk factors for recurrence.

Design: Prospective case series.

Setting: Academic tertiary care centre.

Patients: Between October 1996 and September 2002, 61 patients with HGIN and 288 with BC were included (173 with short-segment and 176 with long-segment Barrett’s oesophagus) from a total of 486 patients presenting with Barrett’s neoplasia. Patients with submucosal or more advanced cancer were excluded.

Interventions: Endoscopic therapy.

Main outcome measures: Rate of complete remission and recurrence rate, tumour-associated death.

Results: Endoscopic resection was performed in 279 patients, photodynamic therapy in 55, and both procedures in 13; two patients received argon plasma coagulation. The mean follow-up period was 63.6 (SD 23.1) months. Complete response (CR) was achieved in 337 patients (96.6%); surgery was necessary in 13 (3.7%) after endoscopic therapy failed. Metachronous lesions developed during the follow-up in 74 patients (21.5%); 56 died of concomitant disease, but none died of BC. The calculated 5 year survival rate was 84%. The risk factors most frequently associated with recurrence were piecemeal resection, long-segment Barrett’s oesophagus, no ablative therapy of Barrett’s oesophagus after CR, time until CR achieved >10 months and multifocal neoplasia.

Conclusions: This study showed that endoscopic therapy was highly effective and safe, with an excellent long-term survival rate. The risk factors identified may help stratify patients who are at risk for recurrence and those requiring more intensified follow-up.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Ethics approval: This study was approved by the Ethics Commission of the Medical Council of the State of Hesse, Germany, in 1996 and was carried out in accordance with the criteria of good clinical practice.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Digest
    Robin Spiller Magnus Simren